Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolysis for acute stroke.

Perttu J Lindsberg1, Markku Kaste

  • 1Department of Neurology, Biomedicum Helsinki, Helsinki University Central Hospital, Helsinki, Finland. perttu.lindsberg@hus.fi

Current Opinion in Neurology
|January 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotics and Their Association With Long-Term Outcomes in Young Ischemic Stroke Patients.

European journal of neurology·2026
Same author

Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke.

Stroke and vascular neurology·2025
Same author

Intravenous thrombolysis versus endovascular thrombectomy in acute basilar artery occlusion-A multicenter cohort study.

International journal of stroke : official journal of the International Stroke Society·2025
Same author

Carotid endarterectomy and the risk of perioperative stroke: The importance of chronic ischaemic lesions and small vessel disease.

European journal of neurology·2025
Same author

Long-term cognitive and neurovascular changes after carotid endarterectomy.

Journal of the neurological sciences·2024
Same author

Etiologic subtypes of first and recurrent ischemic stroke in young patients using A-S-C-O and TOAST classification criteria: A retrospective follow-up study.

European stroke journal·2024
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Stroke thrombolysis using recombinant tissue plasminogen activator is safe and effective within 3 hours. Further research is needed to expand treatment windows and patient eligibility, alongside improved healthcare professional education.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Emergency Medicine

Background:

  • Stroke thrombolysis is transitioning from specialized centers to community settings.
  • Recent advancements aim to enhance the safety and effectiveness of acute stroke treatment.

Purpose of the Study:

  • To review recent data on patient selection, imaging, and technical/organizational advances in stroke thrombolysis.
  • To identify areas requiring further research to optimize stroke thrombolysis outcomes.

Main Methods:

  • Review of recently published open series and randomized trials on thrombolysis in community settings.
  • Analysis of clinical parameters, imaging techniques (CT, CT angiography, perfusion imaging), and glucose levels impacting outcomes.

Main Results:

Related Experiment Videos

  • Community-based thrombolysis largely reproduces outcomes from controlled trials.
  • Elevated blood glucose is linked to poorer outcomes and increased hemorrhage risk.
  • Non-contrast CT remains standard, with CT angiography and perfusion imaging offering additional diagnostic value.

Conclusions:

  • Recombinant tissue plasminogen activator thrombolysis is effective and well-tolerated within 3 hours.
  • Future trials will explore extended time windows and new patient populations, including pediatric stroke.
  • Enhanced education for healthcare personnel is crucial for improving acute stroke care and thrombolysis impact.